These findings are supported by the study by Bhandari et al. [54], who revealed overexpression of POLR2D in multiple cancers, and also showed the POLR2L gene to be hypermethylated in a non-small-cell lung cancer cell line. The gene discussed is POLR2D; the disease is non-small cell lung carcinoma.